Clinical Trials Logo

Clinical Trial Summary

This study examines circadian rhythms and morningness-eveningness preference in youth with Persistent Tic Disorders (PTDs), including Tourette's Disorder (TD); and assesses the effects of wearable short wavelength light therapy on circadian rhythms and tic symptoms.


Clinical Trial Description

Many individuals with Persistent Tic Disorders (PTDs), including Tourette's Disorder (TD) fail to significantly benefit from existing tic treatments. Case studies have shown morning exposure to light therapy, known to advance circadian phase is associated with modest to large tic reductions (Coles & Strauss, 2013; Niederhofer, 2003) suggesting the presence of circadian abnormalities (i.e., phase delay) in select individuals with PTDs. The present project assesses circadian phase and morningness-eveningness preference in youth with Persistent Tic Disorders (PTDs), including Tourette's Disorder (TD), and examines whether morning use of wearable short wavelength light therapy is associated with shifts in circadian rhythms and reductions in tic severity. Study participation will take place over a three-week period. Clinician-rated tic interview and rating scales of morningness-eveningness preference, sleep, tic, and other symptoms will be completed during an initial screening assessment. Participants will then monitor sleep at home using an actigraph for one week and return for a baseline clinical assessment of tic severity and evening assessment of internal melatonin levels involving saliva sampling every 30 minutes for 6.5 hours in a dimly lit room. Next, participants will complete an abbreviated course (i.e., two weeks) of morning light therapy using wearable short wavelength (i.e., blue-green) light-emitting glasses while continuing to monitor sleep using the actigraph. Following this two-week period participants will return for a final assessment of tic severity and internal melatonin levels. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03508245
Study type Interventional
Source University of California, Los Angeles
Contact
Status Completed
Phase N/A
Start date January 18, 2018
Completion date June 23, 2023

See also
  Status Clinical Trial Phase
Completed NCT02316145 - Internet-based Coaching for Young Adults With Neuropsychiatric Disorders N/A
Completed NCT00706589 - Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder Phase 3
Completed NCT01416441 - Safety and Tolerability Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Completed NCT01727700 - Study Evaluating the Safety and Efficacy of Fixed-dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Recruiting NCT06408662 - Remote Delivery of a Mindfulness-based Intervention for Tics N/A
Completed NCT01315327 - Omega-3 Fatty Acids in Tourette's Disorder N/A
Completed NCT01795105 - ABF Tourette's Disorder Post Marketing Surveillance Study
Completed NCT01418339 - Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Completed NCT01585207 - Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder Phase 1/Phase 2
Completed NCT01727713 - Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder Phase 3
Completed NCT03042507 - Psychosocial Intervention for Young Children With Chronic Tics N/A
Completed NCT02864589 - Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder N/A
Completed NCT02413216 - TicHelper: A Computerized Comprehensive Behavioral Intervention for Tics (CBIT) N/A
Completed NCT01177774 - Assessment of Children With Tic Onset in the Past 6 Months
Completed NCT01418352 - Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD) Phase 3
Recruiting NCT05499741 - Forehead Temperature-Regulating Therapy for Insomnia in Adults With Tourette's Disorder N/A
Completed NCT03916055 - Internet-delivered Behaviour Therapy for Children and Adolescents With Tourette's Disorder N/A